Sylebra Capital LLC grew its position in Xometry, Inc. (NASDAQ:XMTR - Free Report) by 2.6% in the first quarter, according to its most recent filing with the SEC. The fund owned 1,881,624 shares of the company's stock after acquiring an additional 46,874 shares during the period. Xometry accounts for approximately 2.4% of Sylebra Capital LLC's investment portfolio, making the stock its 11th biggest position. Sylebra Capital LLC owned 3.74% of Xometry worth $46,890,000 at the end of the most recent reporting period.
Several other large investors have also bought and sold shares of the stock. Vanguard Group Inc. raised its position in Xometry by 2.8% during the 1st quarter. Vanguard Group Inc. now owns 4,413,337 shares of the company's stock worth $109,980,000 after purchasing an additional 120,065 shares during the last quarter. New York State Common Retirement Fund raised its position in shares of Xometry by 4.4% in the 1st quarter. New York State Common Retirement Fund now owns 942,088 shares of the company's stock worth $23,477,000 after acquiring an additional 39,480 shares in the last quarter. Ameriprise Financial Inc. raised its position in shares of Xometry by 225.7% in the 4th quarter. Ameriprise Financial Inc. now owns 852,813 shares of the company's stock worth $36,381,000 after acquiring an additional 590,974 shares in the last quarter. Baillie Gifford & Co. raised its position in shares of Xometry by 2.5% in the 1st quarter. Baillie Gifford & Co. now owns 728,281 shares of the company's stock worth $18,149,000 after acquiring an additional 18,085 shares in the last quarter. Finally, Next Century Growth Investors LLC raised its position in shares of Xometry by 194.1% in the 1st quarter. Next Century Growth Investors LLC now owns 664,292 shares of the company's stock worth $16,554,000 after acquiring an additional 438,393 shares in the last quarter. 97.31% of the stock is owned by institutional investors.
Analyst Ratings Changes
Several research firms have recently weighed in on XMTR. UBS Group lifted their price objective on Xometry from $35.00 to $40.00 and gave the stock a "neutral" rating in a research report on Wednesday, August 6th. JPMorgan Chase & Co. raised their target price on Xometry from $36.00 to $38.00 and gave the company an "overweight" rating in a research note on Tuesday, June 3rd. Citigroup restated an "outperform" rating on shares of Xometry in a research note on Friday, July 11th. Cantor Fitzgerald upgraded Xometry from an "underweight" rating to a "neutral" rating and set a $41.00 target price for the company in a research note on Tuesday, August 5th. Finally, JMP Securities raised their target price on Xometry from $45.00 to $50.00 and gave the company a "market outperform" rating in a research note on Wednesday, August 6th. Six investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $40.44.
View Our Latest Stock Report on Xometry
Xometry Trading Up 1.3%
XMTR traded up $0.67 during trading on Friday, hitting $51.30. 248,605 shares of the stock traded hands, compared to its average volume of 716,865. The firm has a market capitalization of $2.61 billion, a P/E ratio of -41.71 and a beta of 0.87. The company has a debt-to-equity ratio of 1.20, a current ratio of 3.91 and a quick ratio of 3.85. The firm has a 50-day moving average of $41.27 and a 200 day moving average of $32.78. Xometry, Inc. has a 12-month low of $16.26 and a 12-month high of $51.87.
Xometry (NASDAQ:XMTR - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.05 by $0.04. The company had revenue of $162.55 million during the quarter, compared to the consensus estimate of $156.53 million. Xometry had a negative net margin of 10.20% and a negative return on equity of 6.79%. Xometry's revenue was up 22.6% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.01) earnings per share. Xometry has set its Q3 2025 guidance at EPS. Equities research analysts anticipate that Xometry, Inc. will post -0.66 EPS for the current year.
Insiders Place Their Bets
In related news, CFO James Miln sold 598 shares of the stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $50.25, for a total transaction of $30,049.50. Following the completion of the sale, the chief financial officer owned 144,115 shares of the company's stock, valued at $7,241,778.75. This represents a 0.41% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Randolph Altschuler sold 9,332 shares of the business's stock in a transaction that occurred on Wednesday, July 2nd. The stock was sold at an average price of $32.39, for a total transaction of $302,263.48. Following the sale, the chief executive officer directly owned 319,602 shares in the company, valued at approximately $10,351,908.78. This represents a 2.84% decrease in their position. The disclosure for this sale can be found here. Insiders own 9.66% of the company's stock.
Xometry Company Profile
(
Free Report)
Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.
Read More

Before you consider Xometry, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xometry wasn't on the list.
While Xometry currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report